Product class:
|
Medicinal product with marketing authorization
|
Medicinal product class:
|
Veterinary medicine
|
Name of medicinal product:
|
Cortico Veyxin
|
Active substances:
|
|
ATC code:
|
QH02AB06
|
Dosage form:
|
suspension for injection
|
Strength:
|
8,95mg 1ml
|
Legal status for supply*:
|
Subject to medicinal prescription
|
Summary of product characteristics (SPC):
|
(last updated May 26, 2023)
|
Package information leaflet (PIL):
|
EST (last updated September 5, 2018)
|
Labelling:
|
(last updated September 5, 2018)
|
Indication:
|
In horses, cattle, dogs and cats:
Supportive treatment of acute non-infectious arthritis, bursitis, tenosynovitis or allergic skin disease.
In cattle:
Supportive treatment of primary ketosis (acetonaemia).
|
Safety features:
|
No
|
Marketing authorization holder:
|
Veyx-Pharma GmbH
|
Marketing authorization number:
|
2113
|
Marketing authorization issued on:
|
September 5, 2018
|
Marketing authorization expires on:
|
Unlimited
|
Marketing authorization procedure type:
|
Decentralised
|
Assessment report:
|
(last updated September 19, 2018)
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
1710201
|
Cortico Veyxin
|
suspension for injection
|
8,95mg 1ml 100ml 1TK
|
Prescription
|
|
|
|
|
|
1710212
|
Cortico Veyxin
|
suspension for injection
|
8,95mg 1ml 100ml 6TK
|
Prescription
|
|
|
|
|
|
1710223
|
Cortico Veyxin
|
suspension for injection
|
8,95mg 1ml 100ml 12TK
|
Prescription
|
|
|
|
|
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere